Background/Aims: The aim of this prospective study was to determine ionized and total magnesium (Mg) levels in pregnant subjects with and without gestational diabetes mellitus (GDM). Methods: Eighty-five women, 26-28 weeks pregnant, were recruited for routine oral glucose tolerance tests (OGTT); 45 had normal OGTT results and 40 were diagnosed with GDM. Electrolyte levels, including ionized and total Mg, were analyzed. Results: Gestational age and BMI were similar between the two groups (p = 0.800, p = 0.025). Multivitamin use was higher in the control group (p = 0.036). Fasting blood glucose was higher in the GDM group (p < 0.001). The median total Mg levels were 1.9 mg/dl (range 1.6-2.2) in the control group and 1.8 mg/dl (range 1.2-2.1) in the GDM group (p < 0.001). The median ionized Mg levels were 0.5 mmol/l (range 0.4-0.6) in the control group and 0.4 mmol/l (range 0.4-0.5) in the GDM group (p < 0.001). Conclusion: Our study revealed a relationship between low total and ionized Mg levels and GDM, as in type 2 diabetes mellitus (DM). The literature regarding type 2 DM and our findings suggest that Mg is the key ion in the pathophysiology of GDM. Low-dose Mg supplementation was not related to GDM; however, pharmacological doses in the various stages of pregnancy could be beneficial and should be investigated.

1.
American Diabetes Association: Standards of medical care in diabetes - 2013. Diabetes Care 2013;36(suppl 1):S11-S66.
2.
Buchanan TA, Xiang AH: Gestational diabetes mellitus. J Clin Invest 2005;115:485-491.
3.
Kousta E, Lawrence NJ, Godsland IF, Penny A, Anyaoku V, Millauer BA, Cela E, Johnston DG, Robinson S, McCarthy MI: Insulin resistance and beta-cell dysfunction in normoglycaemic European women with a history of gestational diabetes. Clin Endocrinol (Oxf) 2003;59:289-297.
4.
Saucedo R, Zarate A, Basurto L, Hernandez M, Puello E, Campos S, Moreno E: Women with gestational diabetes develop glucose intolerance with high frequency within one year postpartum. Gynecol Obstet Invest 2012;73:58-62.
5.
Lima Mde L, Cruz T, Rodrigues LE, Bomfim O, Melo J, Correia R, Porto M, Cedro A, Vicente E: Serum and intracellular magnesium deficiency in patients with metabolic syndrome - evidences for its relation to insulin resistance. Diabetes Res Clin Pract 2009;83:257-262.
6.
Resnick LM: Ionic basis of hypertension, insulin resistance, vascular disease, and related disorders: the mechanism of ‘syndrome X'. Am J Hypertens 1993;6:123S-134S.
7.
Srinivasan AR, Niranjan G, Kuzhandai Velu V, Parmar P, Anish A: Status of serum magnesium in type 2 diabetes mellitus with particular reference to serum triacylglycerol levels. Diabetes Metab Syndr 2012;6:187-189.
8.
Bardicef M, Bardicef O, Sorokin Y, Altura BM, Altura BT, Cotton DB, Resnick LM: Extracellular and intracellular magnesium depletion in pregnancy and gestational diabetes. Am J Obstet Gynecol 1995;172:1009-1013.
9.
Ertbeg P, Norgaard P, Bang L, Nyholm H, Rudnicki M: Ionized magnesium in gestational diabetes. Magnes Res 2004;17:35-38.
10.
Borella P, Szilagyi A, Than G, Csaba I, Giardino A, Facchinetti F: Maternal plasma concentrations of magnesium, calcium, zinc and copper in normal and pathological pregnancies. Sci Total Environ 1990;99:67-76.
11.
Wang Y, Tan M, Huang Z, Sheng L, Ge Y, Zhang H, Jiang M, Zhang G: Elemental contents in serum of pregnant women with gestational diabetes mellitus. Bio Trace Elem Res 2002;88:113-118.
12.
American Diabetes Association: Gestational diabetes mellitus. Diabetes Care 2004;27(suppl 1):S88-S90.
13.
Kim C, Newton KM, Knopp RH: Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 2002;25:1862-1868.
14.
Retnakaran R: Glucose tolerance status in pregnancy: a window to the future risk of diabetes and cardiovascular disease in young women. Curr Diabetes Rev 2009;5:239-244.
15.
Tam WH, Ma RC, Yang X, Ko GT, Lao TT, Chan MH, Lam CW, Cockram CS, Chan JC: Cardiometabolic risk in Chinese women with prior gestational diabetes: a 15-year follow-up study. Gynecol Obst Invest 2012;73:168-176.
16.
Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A: Magnesium: an update on physiological, clinical and analytical aspects. Clin Chim Acta 2000;294:1-26.
17.
Laurant P, Touyz RM: Physiological and pathophysiological role of magnesium in the cardiovascular system: implications in hypertension. J Hypertens 2000;18:1177-1191.
18.
Chaudhary DP, Sharma R, Bansal DD: Implications of magnesium deficiency in type 2 diabetes: a review. Biol Trace Elem Res 2010;134:119-129.
19.
Seyoum B, Siraj ES, Saenz C, Abdulkadir J: Hypomagnesemia in Ethiopians with diabetes mellitus. Ethn Dis 2008;18:147-151.
20.
Kuoppala T: Alterations in vitamin D metabolites and minerals in diabetic pregnancy. Gynecol Obstet Invest 1988;25:99-105.
21.
Mimouni F, Miodovnik M, Tsang RC, Holroyde J, Dignan PS, Siddiqi TA: Decreased maternal serum magnesium concentration and adverse fetal outcome in insulin-dependent diabetic women. Obstet Gynecol 1987;70:85-88.
22.
Wibell L, Gebre-Medhin M, Lindmark G: Magnesium and zinc in diabetic pregnancy. Acta Paediatr Scand Suppl 1985;320:100-106.
23.
Evangelopoulos AA, Vallianou NG, Panagiotakos DB, Georgiou A, Zacharias GA, Alevra AN, Zalokosta GJ, Vogiatzakis ED, Avgerinos PC: An inverse relationship between cumulating components of the metabolic syndrome and serum magnesium levels. Nutr Res 2008;28:659-663.
24.
Guerrero-Romero F, Rascon-Pacheco RA, Rodriguez-Moran M, de la Pena JE, Wacher N: Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study. Eur J Clin Invest 2008;38:389-396.
25.
Gimenez MS, Oliveros LB, Gomez NN: Nutritional deficiencies and phospholipid metabolism. Int J Mol Sci 2011;12:2408-2433.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.